Browse by ["viewname_eprint_publisher" not defined]

B

Banas, Bernhard and Boeger, Carsten and Lueckhoff, Gerhard and Krueger, Bernd and Barabas, Sascha and Tudor, Silke and Batzilla, Julia and Schemmerer, Mathias and Bendfeldt, Hanna and Koestler, Josef and Wagner, Ralf and Deml, Ludwig and Leicht, Joachim and Kraemer, Bernhard K. (2015) VALIDATION OF THE SUITABILITY OF A NOVEL ELISPOT ASSAY TO ASSESS THE FUNCTIONALITY OF CELL-MEDIATED IMMUNITY (CMI) IN HEMODIALYSIS PATIENTS. WILEY-BLACKWELL, HOBOKEN.

Banas, M. and Pagel, P. and Neumann, S. and Krumpel, A. and Eiglsperger, J. and Chittka, D. and Kraemer, B. and Banas, B. (2015) NON-INVASIVE MONITORING OF RENAL ALLOGRAFT FUNCTION BY NMR-BASED URINE METABOLOMICS. WILEY-BLACKWELL, HOBOKEN.

Benck, U. and Schnuelle, P. and Habicht, A. and Renders, L. and Zeier, M. and Heller, K. and Pisarski, P. and Banas, B. and Kraemer, B. K. and Jung, M. and Lopau, K. and Olbricht, C. -J. and Weihprecht, H. and Schenker, P. and De Fijter, H. W. and Yard, B. and Schmitt, W. H. (2015) EFFECTS OF DOPAMINE DONOR PRETREATMENT ON GRAFT FUNCTION AFTER KIDNEY TRANSPLANTATION: FIVE-YEAR FOLLOW-UP OF A RANDOMIZED CONTROLLED TRIAL. WILEY-BLACKWELL, HOBOKEN.

Budde, K. and Reinke, P. and Rath, T. and Suwelack, B. and Kraemer, B. K. and Banas, B. (2015) COMET: EVALUATION OF COMPLIANCE AND TOLERABILITY OF ONCE DAILY TACROLIMUS (ADVAGRAF) IN KIDNEY TANSPLANT-PATIENTS. WILEY-BLACKWELL, HOBOKEN.

C

Campbell, Scott and Eris, Josette and Brown, Fiona and Russ, Graeme and Caicedo, Luis and Walker, Rowan and Kraemer, Bernhard and Haas, Tomas (2005) EXCELLENT GRAFT FUNCTION IN DE NOVO KIDNEY TRANSPLANT RECIPIENTS TREATED WITH CERTICAN (R), SIMULECT (R) AND REDUCED NEORAL (R) EXPOSURE: 24 MONTH RESULT. In: 3RD WORLD CONGRESS OF NEPHROLOGY, June 26-30, 2005, Singapore.

Cumpelik, A. and Gerossier, E. and Jin, J. and Tsakiris, D. and Dickenmann, M. and Sadallah, S. and Schifferli, J. A. and Zecher, D. (2015) Mechanism of Platelet Activation and Hypercoagulability by Antithymocyte Globulins (ATG). AMERICAN JOURNAL OF TRANSPLANTATION, 15 (10). pp. 2588-2601. ISSN 1600-6135, 1600-6143

F

Faria, D. and Martins, J. and Kongsuphol, P. and Reisch, B. and Schreiber, R. and Kunzelmann, K. (2012) ANOCTAMIN 6 IS AN ESSENTIAL COMPONENT OF THE OUTWARDLY RECTIFYING CHLORIDE CHANNEL (ORCC) AND IS UPREGULATED BY CFTR EXPRESSION. PEDIATRIC PULMONOLOGY, 47 (Supp35). p. 235. ISSN 8755-6863

Fuchs, A. and Eidenschink, K. and Wurm, S. and Gronwald, W. and Bollheimer, C. and Banas, B. and Banas, M. (2014) AGE-RELATED CHANGES IN RAT DONOR KIDNEYS RELEVANT FOR ORGAN QUALITY AND FUNCTION. WILEY-BLACKWELL, HOBOKEN.

H

Hutchinson, James A. and Ahrens, Norbert and Riquelme, Paloma and Walter, Lisa and Gruber, Michael and Boeger, Carsten A. and Farkas, Stefan and Scherer, Marcus N. and Broichhausen, Christiane and Bein, Thomas and Schlitt, Hans-J. and Faendrich, Fred and Banas, Bernhard and Geissler, Edward K. (2014) Clinical management of patients receiving cell-based immunoregulatory therapy. WILEY-BLACKWELL, HOBOKEN.

K

Kauke, T. and Breidenbach, T. and Boesebeck, D. and Schoenermarck, U. and Banas, B. and Guba, M. and Stangl, M. and Schnuelle, P. and Vogeser, M. and Kraemer, B. K. and Fischereder, M. (2011) SERUM ERYTHROPOIETIN-LEVELS OF DECEASED ORGAN DONORS (DEPO) ARE PREDICTIVE OF DELAYED GRAFT FUNCTION (DGF) AFTER RENAL TRANSPLANTATION. TRANSPLANT INTERNATIONAL, 24 (Suppl3). p. 10. ISSN 0934-0874

Kuehne, L. and Jung, B. and Reinfrank, H. and Schuster, A. and Banas, B. and Bergler, T. (2016) INTRA-RENAL B CELL POPULATIONS, B CELL PROLIFERATION FACTORS AND ANTIBODY FORMATION IN A MODEL OF NON-ADHERENCE. WILEY-BLACKWELL, HOBOKEN.

Kuehne, L. and Jung, B. and Reinfrank, H. and Wurm, S. and Banas, B. and Bergler, T. (2015) EARLY LEUKOCYTE INFILTRATION AND EXPRESSION OF B-CELL ACTIVATING FACTORS IN A KIDNEY TRANSPLANT MODEL. WILEY-BLACKWELL, HOBOKEN.

N

Nashan, B. and Spetzler, V. and Schemmer, P. and Kirste, G. and Rahmel, A. (2015) Regarding "Compared Efficacy of Preservation Solutions in Liver Transplantation: A Long-Term Graft Outcome Study From the European Liver Transplant Registry". AMERICAN JOURNAL OF TRANSPLANTATION, 15 (12). pp. 3272-3273. ISSN 1600-6135, 1600-6143

P

Proneth, A. and Schnitzbauer, A. and Viebahn, R. and Schenker, P. and Arbogast, H. and Manekeller, S. and Nadalin, S. and Heise, M. and Stroehlein, M. and Banas, B. and Schemmer, P. and Becker, T. and Bechstein, W. and Pascher, A. and Rauchfuss, F. and Geissler, E. and Schlitt, H. -J. and Farkas, S. (2016) EXTENDED PANCREAS DONOR PROGRAM - THE EXPAND STUDY: A PROSPECTIVE MULTICENTER TRIAL TESTING THE USE OF PANCREAS DONORS OVER AGE 50. WILEY-BLACKWELL, HOBOKEN.

S

Schiechl, Gabriela and Hermann, Fabian and Gomez, Manuel Rodriguez and Kutzi, Simone and Schmidbauer, Kathrin and Talke, Yvonne and Neumayer, Sophia and Goebel, Nicole and Karasuyama, Hajime and Obata-Ninomiya, Kazushige and Bruehl, Hilke and Geissler, Edward and Fichtner-Feigl, Stefan and Mack, Matthias (2015) IMPORTANT CONTRIBUTION OF BASOPHILS TO DEVELOPMENT OF CARDIAC ALLOGRAFT FIBROSIS. WILEY-BLACKWELL, HOBOKEN.

Z

Zecher, D. and Bach, C. and Staudner, C. and Banas, B. and Spriewald, B. and Boeger, C. (2016) CHARACTERISTICS OF PRE-TRANSPLANT DONOR-SPECIFIC ANTI-HLA ANTIBODIES AND OUTCOME IN KIDNEY TRANSPLANT PATIENTS TREATED WITH A STANDARDIZED INDUCTION REGIMEN. WILEY-BLACKWELL, HOBOKEN.

Zecher, D. and Bach, C. and Staudner, C. and Banas, B. and Spriewald, B. and Boeger, C. (2016) CLINICAL UTILITY OF LUMINEX-BASED ANALYSIS OF PRETRANSPLANT ANTI-HLA ANTIBODIES FOR THE DEFINITION OF UNACCEPTABLE HLA ANTIGEN MISMATCHES IN RENAL TRANSPLANTATION. WILEY-BLACKWELL, HOBOKEN.

Zecher, D. and Cumpelik, A. and Ruhland, B. and Banas, B. and Hopfer, H. and Dickenmann, M. and Schifferli, J. (2016) Plasma Endothelial Microvesicle Counts Indicate Allograft Rejection Following Kidney Transplantation. AMERICAN JOURNAL OF TRANSPLANTATION, 16 (Suppl3). p. 459. ISSN 1600-6135, 1600-6143

Zecher, D. and Cumpelik, A. and Tsakiris, D. and Dickenmann, M. and Schifferli, J. (2015) Antithymocyte Globulin-Induced Platelet Hypercoagulability Is a Consequence of Complement Activation and Microvesicle Release. WILEY-BLACKWELL, HOBOKEN.